US Broker Ratings

NovoCure Limited (NVCR) Stock Analysis: Exploring a 119% Potential Upside Amidst Market Challenges

NovoCure Limited (NASDAQ: NVCR), a prominent player in the healthcare sector, specifically within the medical devices industry, offers a portfolio focused on innovative oncology solutions. The..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: Exploring a Potential 147% Upside in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX) has caught the eye of investors, thanks in part to its substantial potential upside of 147.11%, according to recent analyst ratings...

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Exploring a Strong 19.2% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is capturing the attention of investors with its promising 19.2% upside potential, underpinned by a robust pipeline and strategic collaborations. As..

Arcellx, Inc. (ACLX) Stock Analysis: 32% Potential Upside Amidst Biotech Innovations

Arcellx, Inc. (NASDAQ: ACLX) is steadily carving out a niche in the rapidly evolving biotechnology sector. Headquartered in Redwood City, California, Arcellx is engaged in the..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Promising 70% Potential Upside in the Biotech Sector

Apogee Therapeutics, Inc. (NASDAQ: APGE) appears to be a rising star in the biotechnology sector, with a market capitalization of $3.88 billion and a compelling narrative..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating a 7.52% Upside Potential Amidst Biotech Breakthroughs

PTC Therapeutics, Inc. (NASDAQ: PTCT), a key player in the biotechnology sector, has been making waves in the healthcare industry with its focus on rare disorders...

Harmony Biosciences Holdings (HRMY) Stock Analysis: A Biotech Gem with 39.99% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) represents an intriguing opportunity within the biotechnology sector for investors looking to gain exposure to a company with a promising..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

CG Oncology, Inc. (CGON) Stock Analysis: A Promising Biotech with 69% Upside Potential

Investors looking for promising opportunities in the biotechnology sector should pay close attention to CG Oncology, Inc. (NASDAQ: CGON). With a market capitalization of $3.07 billion..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Unlocking a 48% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a prominent player in the healthcare sector, particularly in the medical care facilities industry, is capturing the attention of investors..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 27% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS) is garnering attention within the healthcare sector, primarily due to its robust growth trajectory and promising upside potential reflected in recent..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Biotech Contender with 36% Upside Potential

MoonLake Immunotherapeutics (MLTX), a clinical-stage biotechnology firm based in Zug, Switzerland, is making waves in the healthcare sector with its innovative approach to treating inflammatory skin..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unpacking the 102.56% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of biopharmaceutical innovation, developing groundbreaking therapeutics for neurodegenerative and lysosomal storage diseases. With a market capitalization of..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 90% Upside Potential

QuidelOrtho Corporation (NASDAQ: QDEL) stands out in the healthcare sector with its focus on medical devices, providing a robust range of diagnostic testing solutions. Headquartered in..

Sotera Health Company (SHC) Stock Analysis: Exploring a 20% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC) stands as a formidable entity within the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: Exploring an 88.98% Potential Upside in the Biotech Sphere

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is making waves in the biotechnology sector with its innovative approach to tackling rare endocrine diseases and endocrine-related tumors. The company,..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: Unpacking a 61.68% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a commercial-stage biopharmaceutical company that is making waves in the healthcare sector with its focus on rare diseases. With a..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring Its 7.86% Upside Potential Amid Clinical Advancements

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a notable player in the biotechnology sector, is drawing attention with its robust market presence and promising pipeline of drug candidates...

Immunovant, Inc. (IMVT) Stock Analysis: A Promising 64.60% Upside Potential in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT) is capturing investor attention with a compelling potential upside of 64.60%, according to recent analyst ratings. This clinical-stage biopharmaceutical company, based in..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: Unpacking a 58.48% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) has piqued the interest of investors with its promising biotechnology advancements and a striking 58.48% potential stock price upside. Specializing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds